IRCT20200509047373N1招募中2 期
Evaluation effects of DINVL herbal medicine on the recovery of patients with COVID - 19
Health Medicine Chemistry Company0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients up18 years old hospitalized
- •Patient with SpO2:85-89% on room air at admission (if correct with nasal O2 maximum 6 liter/min to SpO2>=90 )
- •Patients with SpO2: 90-93% and RR>=30 clinical compatible
- •patients with positive RT-PCR test or consistent HRCT to covid19
- •pneumonia Sign the study participation form
排除标准
- •Known sensitivity to plant compounds.
- •Pregnant woman Lactating woman Patients with active peptic.
研究者
相似试验
招募中
不适用
An Observational Study on Effect of Herbal Medicine Treatment and Change of Gut Microbiome in Functional Dyspepsia PatientsDiseases of the digestive systemKCT0005439Daejeon Korean Medicine Hospital of Daejeon University10
已完成
2 期
Evaluation of the effects of herbal medicine (Mixture) ?on Polycystic ovary syndrome (PCOS) in women and girls with PCOS sign and symptomPolycystic ovarian syndromePolycystic ovary syndrome.IRCT201609015942N4Vice chancellor for Research,Tabriz University Of Medical Sciences60
招募中
3 期
Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patientsIRCT20200404046935N1Mazandaran University of Medical Sciences40
进行中（未招募）
不适用
Evaluation of efficacy and safety of the herbal drug Myrrhinil-Intest vs. mesalazine in maintaining clinical remission of ulcerative colitis - a 12-month, multicenter, randomized, prospective, double-blind, double-dummy, active-controlled and parallel group phase IV-trial - MIRCulcerative colitis patients in clinical remissionMedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2007-007928-18-DEREPHA GmbH
尚未招募
3 期
Evaluation of herbal formulation in contact dermatitisCTRI/2023/07/055420Plant Ayu Life Sciences LLP Pune